Skip to main content

Table 6 Relation between genotypes and socio-demographic data among HCC patients

From: Association between miR-196a2 polymorphism and the development of hepatocellular carcinoma in the Egyptian population

Studied variable

Genotype

Chi-square test

P value

CC

N = 21

TC

N = 42

TT

N = 17

Age (years) X ± SD

52.50 ± 4.628

54.48 ± 4.77

56.06 ± 6.329

2.96*

0.06

No.

(%)

No.

(%)

No.

(%)

  

Gender

 Male

10

(47.6)

20

(47.6)

12

(70.6)

0.49

0.78

 Female

11

(52.4)

22

(52.4)

5

(29.4)

Smoking

 Yes

12

(57. 1)

16

(38. 1)

10

(58.8)

3.15

0.20

 No

9

(42.9)

26

(61.9)

7

(41.2)

Family history

 Yes

5

(23.8)

12

(28.6)

5

(29.4)

0.20

0.90

 No

16

(76.2)

30

(71.4)

12

(70.6)

Spleen

 Average

5

(23.8)

5

(11.9)

1

(5.9)

2.50**

0.25

 Splenomegaly

16

(76.2)

37

(88.1)

16

(94.1)

Liver

 Hepatomegaly

6

(28.6)

7

(16.7)

5

(29.4)

3.01

0.55

 Cirrhotic

14

(66.7)

34

(81.0)

12

(70.6)

 Shrunken

1

(4.8)

1

(2.4)

0

(0.0)

Ascites

 Present

16

(76.2)

38

(90.5)

13

(76.5)

3.20

0.20

 No

5

(23.8)

4

(9.5)

4

(23.5)

Encephalopathy

 Present

12

(57.1)

28

(66.7)

10

(58.8)

0.66

0.71

 Absent

9

(42.9)

14

(33.3)

7

(41.2%)

Child score

 A

7

(33.3)

13

(31.0)

4

(23.5)

1.61**

0.80

 B

6

(28.6)

17

(40.5)

6

(35.3)

 C

8

(38.1)

12

(28.6)

7

(41.2)

  1. *ANOVA test
  2. **Fisher’s exact test